A Study to Evaluate the Effect of Renal Impairment on JNJ-64417184 and Its Two Minor Metabolites JNJ-68294291 and JNJ-65201526 in Adult Participants
Clinical trial NCT04426357 · TERMINATED
Trial details
- NCT number
- NCT04426357
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-03
- Primary completion
- 2020-11-12
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.